Genomic Health Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2015 and for the Year 2016
For the year ended December 31, 2015, the company expects revenue to be between $285 million and $286 million, compared with $275.7 million in 2014, representing an increase of approximately 4%, slightly below the company's 2015 guidance.
For the year 2016, the company is providing initial 2016 revenue guidance between $320 million and $335 million, representing growth of between approximately 12% and 17% compared to 2015.